Cancer remains a formidable global challenge, with its incidence on the rise. Early detection plays a pivotal role in mitigating its impact, offering higher survival rates, less invasive treatments, and reduced emotional burden. This co-publication with CAS, offers a comprehensive overview of cancer biomarkers and their critical role in early detection, providing valuable insights for researchers, healthcare professionals, and stakeholders in the fight against cancer.
Key Highlights:
- Understanding the significance of cancer biomarkers in early detection and treatment.
- Analyzing trends in biomarker research, including types, techniques, and clinical applications.
- Exploring the challenges and opportunities in biomarker development and validation.
- Showcasing real-world data insights from CAS Content Collectionâ„¢ and Excelra’s Biomarker Insights dataset.
- Highlighting promising biomarkers for pancreatic and liver cancers, two challenging-to-detect malignancies.
Download the Publication Now to Uncover the Latest Insights in Cancer Biomarkers and Their Impact on Early Detection and Treatment.
Note: This publication is a collaborative effort between CAS, a division of the American Chemical Society, and Excelra Knowledge Solutions Pvt. Ltd. All rights reserved. No part of this report may be reproduced or distributed without prior written permission.
